These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 4774057)

  • 21. Synthesis, radiosynthesis and biological evaluation of 1,4-dihydroquinoline derivatives as new carriers for specific brain delivery.
    Foucout L; Gourand F; Dhilly M; Bohn P; Dupas G; Costentin J; Abbas A; Marsais F; Barré L; Levacher V
    Org Biomol Chem; 2009 Sep; 7(18):3666-73. PubMed ID: 19707670
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of a multiplex non-radioactive receptor assay: the benzodiazepine receptor, the serotonin transporter and the beta-adrenergic receptor.
    de Jong LA; Jeronimus-Stratingh CM; Cremers TI
    Rapid Commun Mass Spectrom; 2007; 21(4):567-72. PubMed ID: 17245793
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Drug interactions.
    Ober KF; Wang RI
    Wis Med J; 1971 Oct; 70(10):221-3. PubMed ID: 5097865
    [No Abstract]   [Full Text] [Related]  

  • 24. The amiloride receptor.
    Cuthbert AW; Wong PY
    Br J Pharmacol; 1971 Oct; 43(2):416P-417P. PubMed ID: 5158208
    [No Abstract]   [Full Text] [Related]  

  • 25. Placental 57-kDa Ca(2+)-binding protein: regulation of expression and function in trophoblast calcium transport.
    Hershberger ME; Tuan RS
    Dev Biol; 1998 Jul; 199(1):80-92. PubMed ID: 9676194
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis, monoamine transporter binding properties, and behavioral pharmacology of a series of 3beta-(substituted phenyl)-2beta-(3'-substituted isoxazol-5-yl)tropanes.
    Carroll FI; Pawlush N; Kuhar MJ; Pollard GT; Howard JL
    J Med Chem; 2004 Jan; 47(2):296-302. PubMed ID: 14711303
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plasma binding of trichloroacetic acid in mice, rats, and humans under cancer bioassay and environmental exposure conditions.
    Lumpkin MH; Bruckner JV; Campbell JL; Dallas CE; White CA; Fisher JW
    Drug Metab Dispos; 2003 Oct; 31(10):1203-7. PubMed ID: 12975328
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro inhibition of aldosterone-stimulated sodium transport by steroidal spirolactones.
    Porter GA
    Mol Pharmacol; 1968 May; 4(3):224-37. PubMed ID: 5661772
    [No Abstract]   [Full Text] [Related]  

  • 29. Cocaine-induced seizures and lethality appear to be associated with distinct central nervous system binding sites.
    Ritz MC; George FR
    J Pharmacol Exp Ther; 1993 Mar; 264(3):1333-43. PubMed ID: 8450469
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Utility of unbound plasma drug levels and P-glycoprotein transport data in prediction of central nervous system exposure.
    He H; Lyons KA; Shen X; Yao Z; Bleasby K; Chan G; Hafey M; Li X; Xu S; Salituro GM; Cohen LH; Tang W
    Xenobiotica; 2009 Sep; 39(9):687-93. PubMed ID: 19569734
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunology. New tricks for old molecules.
    Ravetch JV; Margulies DH
    Nature; 1994 Nov; 372(6504):323-4. PubMed ID: 7969486
    [No Abstract]   [Full Text] [Related]  

  • 32. Evaluation of oncofetal protein-related mRNA transport activity as a potential early cancer marker in dogs with malignant neoplasms.
    Stromberg PC; Schumm DE; Webb TE; Ward H; Couto CG
    Am J Vet Res; 1995 Dec; 56(12):1559-63. PubMed ID: 8599514
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A discussion of some factors relevant to the study of water transport across frog skin.
    House CR
    Arch Sci Biol (Bologna); 1968; 52(3):209-15. PubMed ID: 5750425
    [No Abstract]   [Full Text] [Related]  

  • 34. [Vitamin A transport mechanism: retinol cell reception and the intracellular proteins that bind vitamin A (a review)].
    Kon' IIa; Natanson AO
    Vopr Med Khim; 1980; 26(1):3-13. PubMed ID: 6989103
    [No Abstract]   [Full Text] [Related]  

  • 35. [Quantitative evaluation of protein-binding interactions].
    Deml F; Kvĕtina J; Láznícek M
    Cesk Farm; 1975 Nov; 24(9):386-9. PubMed ID: 1218405
    [No Abstract]   [Full Text] [Related]  

  • 36. Design of in vivo studies of bioavailability--biometrical considerations.
    Bearman JE; Loewenson RB
    Pharmacology; 1972; 8(1):44-54. PubMed ID: 4644655
    [No Abstract]   [Full Text] [Related]  

  • 37. The validity and meaning of the results of biological assays.
    JERNE NK; WOOD EC
    Biometrics; 1949 Dec; 5(4):273-99. PubMed ID: 15397309
    [No Abstract]   [Full Text] [Related]  

  • 38. Routine computation of biological assays involving a quantitative response.
    HEALY MJ
    Biometrics; 1949 Dec; 5(4):330-4. PubMed ID: 15397311
    [No Abstract]   [Full Text] [Related]  

  • 39. The choice of a response metameter in bio-assay.
    FINNEY DJ
    Biometrics; 1949 Dec; 5(4):261-72. PubMed ID: 15397308
    [No Abstract]   [Full Text] [Related]  

  • 40. The analysis of extinction time data in bioassay.
    MATHER K
    Biometrics; 1949 Jun; 5(2):127-43. PubMed ID: 18151956
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.